Nutra Pharma Corp
SEC CIK 1119643 · nphc · last insider filing 2022-01-14
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Deitsch RIK J | Director · President, CEO, CFO | filed 2008 - 2022 |
| Oran DAN | Director | filed 2017 - 2017 |
| Lonky Stewart Alan | Director | filed 2010 - 2014 |
| Pottruck Garry | Director | filed 2010 - 2014 |
| Rumph Harold Henry | Director · President - ReceptoPharm | filed 2009 - 2014 |
| Cherelstein Stanley Jack | Director | filed 2009 - 2010 |
| Reid Paul F | Director | filed 2010 - 2010 |
| Doherty Michael | Director · Executive Chairman | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Isserman David Michael | Chief Marketing Officer | filed 2010 - 2010 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.